Dr. Song’s research is focused on developing safer and more efficient AAV vectors for liver-target gene therapy. He is working on the evaluation of hepatotoxicity risks in 3D spheroids models for AAV gene therapy.

ADME profiling, Bioanalytical Chemistry, Drug Metabolizing Enzymes, Hepatocytes, LC-MS/MS Adverse Drug Reactions, Drug Metabolism, Drug Safety, Drug-induced Liver Injury, Health Disparities, Oxidative Stress, Pharmacogenetics, Pharmacokinetics, Toxicology

Cohort and Case-Control Studies, Drug Metabolizing Enzymes, Hepatocytes, Omics (Metabolomics, Proteomics, Lipidomics), Translation Research Cardiovascular, Drug Metabolism, Inflammation, Lipid Metabolism and Transport, Obesity, Pharmacogenomics, Pharmacology, Precision Dosing, Precision Medicine, Women’s Health

ADME profiling, Drug Transporters, Hepatocytes, Mathematical Modelling, Primary Cell Culture Drug Metabolism, Drug Transport, Drug-induced Liver Injury, Gastrointestinal, Hepatology, Intracellular Trafficking, Liver Disease, PBPK Modeling, Pharmacokinetics, Toxicology